Hospital mortality rate after 30 days in cancer surgery at HUB (Bellvitge University Hospital) is 0% in patients without comorbidity and 0,4% in those with high comorbidity

According to the clinical documentation and pathological anatomy services of HUB, and the lymphoma registry from the clinical hematology Service of ICO, 5.140 invasive tumors were diagnosed and/or treated in 2010. Among men, prostate, lung, colon and rectum, haematological, urinary bladder, oral cavity/pharynx , liver, stomach, larynx and pancreas tumors represented 80% of the cancer pathology. Breast, colon and rectum, haematological, endometrium, cèrvix, lung, ovary, brain, thyroid gland and pancreas represented 76% among women.

A total of 1.716 of these tumors (roughly 40%) were surgical. Hospital mortality rate in the first 30 days after surgery was 0% in patients without comorbidity; 0,1% in those with low comorbidity; and 0,4% in those with high comorbidity. Sentinel node technique was used in 44% of the skin, breast, cervix, endometrium, ovary and vagina tumors. Microsatellite instability was found in 10% of colorectal tumors, and the presence of HER-2/SNOW gene was studied in 85% of the breast tumors.

Of the 334 surgical patients with breast cancer, 275 (82%) received conservative surgery and 59 (18%) radical surgery. 36 of these (89%) received immediate reconstructive surgery. The tumor Bank of the Pathological Anatomy Service has 626 (36%) samples.

The session “ICO-HUB Hospital Registry of Tumors. Results in 2010.” was held last 3rd July in Bellvitge University Hospital Lecture Hall. It was presented by Dr Alfredo García, Director of Bellvitge University Hospital, and Dr Candela Calle, Director of ICO (Catalan Institute of Oncology). Dr Josepa Ribes, responsible for the Catalonia’s Cancer Registry, also took part in the session as a speaker. She talked about data mining at the ICO-HUB Hospital Registry of Tumors in 2010.

Més Notícies | Más Noticias | More news

Comments are closed.

Home | eHub | Email